John W Thomas
Overview
Explore the profile of John W Thomas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomas J, Jamy O, Shah M, Vachhani P, Go R, Goyal G
Leuk Res
. 2021 Dec;
112:106770.
PMID: 34920340
Background: Primary myelofibrosis (PMF) is associated with morbidity and mortality. Ruxolitinib gained US FDA approval for treatment of intermediate/high-risk PMF in November 2011. We evaluated differences in survival and second...
2.
Smith C, Thomas J, Ruan G, Hyun M, Bansal R, McLaughlin N, et al.
Am J Hematol
. 2021 Oct;
96(12):E464-E468.
PMID: 34661932
No abstract available.
3.
Hammock J, Williams C, Aswani M, Thomas J, Rocque G
JCO Oncol Pract
. 2020 Aug;
16(12):e1489-e1498.
PMID: 32735510
Purpose: Little is known about the provision of oncologic services by Project Access safety net care coordination programs. Materials And Methods: Information on safety net care coordination program locations, health...
4.
Thomas J, Buckley 2nd C
Pediatr Emerg Care
. 2020 May;
36(5):e301-e303.
PMID: 32355073
Objectives: Pneumoperitoneum with peritonitis, although uncommon, is a serious injury encountered in the pediatric emergency department. Although the patients may often appear ill or toxic, they can have normal vital...
5.
Sekeres M, Gore S, Stablein D, DiFronzo N, Abel G, DeZern A, et al.
Leuk Lymphoma
. 2019 May;
60(13):3161-3171.
PMID: 31111762
Myelodysplastic syndromes (MDS), a spectrum of heterogeneous hematopoietic stem cell diseases, vary in clinical severity, response to therapy, and propensity toward progression to acute myeloid leukemia. These are acquired clonal...
6.
Hall J, Patel D, Thomas J, Richards C, Rogers P, Pruitt C
Pediatr Emerg Care
. 2018 Jul;
34(9):603-606.
PMID: 30045353
Objective: The objective of this study is to evaluate the impact of certified child life specialists (CCLSs) on the emotional responses of children undergoing laceration repair in the emergency department...
7.
Thomas J, Cohen M
Front Psychiatry
. 2014 Jul;
5:74.
PMID: 25071607
Despite over 50 years of research into the states of consciousness induced by various meditation practices, no clear neurophysiological signatures of these states have been found. Much of this failure...
8.
Freeman E, McGuire C, Thomas J, Thayer D
Med Care
. 2014 Feb;
52 Suppl 3:S60-6.
PMID: 24561760
Background: Persons with behavioral disorders incur higher healthcare costs. Although they utilize behavioral health (BH) services others do not, they also have higher utilization of medical services Objectives: : To...
9.
Campbell N, Clark J, Stecher V, Thomas J, Callanan A, Donnelly B, et al.
J Sex Med
. 2013 May;
10(7):1842-9.
PMID: 23634714
Introduction: Many products labeled "herbal" or "all natural" (herbal/natural) that claim to enhance sexual performance and imply use for the treatment of erectile dysfunction (ED) are marketed as over-the-counter (OTC)...
10.
Hurst D, Xie Y, Thomas J, Liu J, Edmonds M, Stewart M, et al.
PLoS One
. 2013 Feb;
8(2):e55966.
PMID: 23390556
Breast cancer metastasis suppressor 1 (BRMS1) is a predominantly nuclear protein that suppresses metastasis in multiple human and murine carcinoma cell lines. BRMS1 interacts with several nuclear proteins including SIN3:HDAC...